Xie N - Search Results

1

Ethical perspective on AI hazards to humans: A review.

Chen C, Chen Z, Luo W, Xu Y, Yang S, Yang G, Chen X, Chi X, Xie N, Zeng Z. Chen C, et al. Among authors: xie n. Medicine (Baltimore). 2023 Dec 1;102(48):e36163. doi: 10.1097/MD.0000000000036163. Medicine (Baltimore). 2023. PMID: 38050218 Free PMC article. Review.

2

Advanced nanomaterials for hypoxia tumor therapy: challenges and solutions.

Sundaram A , Peng L , Chai L , Xie Z , Ponraj JS , Wang X , Wang G , Zhang B , Nie G , Xie N , Rajesh Kumar M , Zhang H . Sundaram A , et al. Among authors: xie z, xie n. Nanoscale. 2020 Nov 5;12(42):21497-21518. doi: 10.1039/d0nr06271e. Nanoscale. 2020. PMID: 33094770 Review.

3

Comparative evaluation of 15-minute rapid diagnosis of ischemic heart disease by high-sensitivity quantification of cardiac biomarkers.

He S, Qu L, He X, Zhang D, Xie N. He S, et al. Among authors: xie n. Exp Ther Med. 2020 Aug;20(2):1702-1708. doi: 10.3892/etm.2020.8853. Epub 2020 Jun 10. Exp Ther Med. 2020. PMID: 32742399 Free PMC article.

4

Perspectives on the Role of Histone Modification in Breast Cancer Progression and the Advanced Technological Tools to Study Epigenetic Determinants of Metastasis.

Zhuang J, Huo Q, Yang F, Xie N. Zhuang J, et al. Among authors: xie n. Front Genet. 2020 Oct 29;11:603552. doi: 10.3389/fgene.2020.603552. eCollection 2020. Front Genet. 2020. PMID: 33193750 Free PMC article. Review.

5

Emerging combination strategies with phototherapy in cancer nanomedicine.

Xie Z , Fan T , An J , Choi W , Duo Y , Ge Y , Zhang B , Nie G , Xie N , Zheng T , Chen Y , Zhang H , Kim JS . Xie Z , et al. Among authors: xie n. Chem Soc Rev. 2020 Nov 21;49(22):8065-8087. doi: 10.1039/d0cs00215a. Epub 2020 Jun 22. Chem Soc Rev. 2020. PMID: 32567633 Review.

6

Comprehensive Analysis of the Expression and Prognosis for Tripartite Motif-Containing Genes in Breast Cancer.

Ning L, Huo Q, Xie N. Ning L, et al. Among authors: xie n. Front Genet. 2022 Jul 19;13:876325. doi: 10.3389/fgene.2022.876325. eCollection 2022. Front Genet. 2022. PMID: 35928444 Free PMC article.

7

Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis.

Huo Q, Ning L, Xie N. Huo Q, et al. Among authors: xie n. Breast Cancer (Dove Med Press). 2023 Mar 10;15:213-226. doi: 10.2147/BCTT.S400808. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 36926265 Free PMC article.

8

SIRT7 Downregulation Promotes Breast Cancer Metastasis Via LAP2α-Induced Chromosomal Instability.

Huo Q, Chen S, Zhuang J, Quan C, Wang Y, Xie N. Huo Q, et al. Among authors: xie n. Int J Biol Sci. 2023 Mar 5;19(5):1528-1542. doi: 10.7150/ijbs.75340. eCollection 2023. Int J Biol Sci. 2023. PMID: 37056924 Free PMC article.

9

A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1/MED29 and ELK4/MED29 axes.

Yang W, Gao K, Qian Y, Huang Y, Xiang Q, Chen C, Chen Q, Wang Y, Fang F, He Q, Chen S, Xiong J, Chen Y, Xie N, Zheng D, Zhai R. Yang W, et al. Among authors: xie n. J Hematol Oncol. 2022 May 7;15(1):53. doi: 10.1186/s13045-022-01270-y. J Hematol Oncol. 2022. PMID: 35526007 Free PMC article.

10

Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.

Zheng YZ, Li JY, Ning LW, Xie N. Zheng YZ, et al. Among authors: xie n. Breast Cancer (Dove Med Press). 2022 Dec 21;14:475-487. doi: 10.2147/BCTT.S387209. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 36578908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,361 results

Search Page